Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

 

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Biologics and biosimilars litigation update

2020年8月7日
QUICK READ

作者 Matthew Royle, Ph.D.

点击此处了解更多
robotic-arm
英国脱欧

Brexit readiness for overseas medical devices manufacturers: trade marks

2020年8月6日
QUICK READ

作者

点击此处了解更多
酒店与休闲

Paul England writes on COVID-19 drug supply and patent system for Manufacturing Chemist

2020年8月6日
QUICK READ

作者 Paul England, DPhil

点击此处了解更多
酒店与休闲

Return to work: key issues for life sciences

2020年8月4日
QUICK READ

作者 Helen Farr 以及 Adrian Toutoungi

点击此处了解更多

与我会面: